Literature DB >> 7150473

Morphology of draining lymph nodes after local immune stimulation with C. parvum: comparison of pelvic nodes in carcinoma of cervix and popliteal and inguinal nodes of guinea-pig.

M H Mignot, J W Lens, J G Stolk, J Oort, R W Veldhuizen, G H Dijkhuizen, H A Drexhage.   

Abstract

Morphological changes are described in pelvic lymph nodes excised 10 days after C. parvum (CP) treatment of patients with cervical carcinoma. Guinea-pig popliteal and inguinal lymph nodes were investigated from Days 1 to 10 after an injection of 70 micrograms CP into the footpad. Eosinophils were detected from the first few hours after stimulation, initially in the marginal sinus, then in the medullary sinuses and subsequently in the efferent lymphatics. From Day 2 to Day 6, histiocyte accumulations with the appearance of epithelioid cells were found mainly in subcapsular and interfollicular areas, and small granulomas were also seen in the paracortex. The granuloma formation in the lymph node was considered as an indication of the activation of histiocytes. Besides small granulomas in the paracortex, activated interdigitating cells, surrounded by scattered lymphoblasts and eosinophils, were also present. We considered this lymphoblastic response and eosinophilic accumulation as likely to be due to blastogenic factor and eosinophil stimulation promotor. Eight to 10 days after CP stimulation, the macrophage lymphoblast eosinophil response was replaced by a B-cell reaction: germinal-centre activation and medullary plasma cells. Such a B-cell reaction was also found in the human pelvic nodes removed at operation, but this reaction could not be attributed to CP treatment alone, since cervical-carcinoma patients not treated with CP also showed such reactions. In contrast, pelvic lymph nodes removed at necropsy from females killed in traffic accidents showed no predominance of either B- or T-cell stimulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7150473      PMCID: PMC2011104          DOI: 10.1038/bjc.1982.184

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Histologic reactions of the thymus, spleen, liver and lymph nodes to intravenous and subcutaneous BCG injections.

Authors:  A Khalil; C Bourut; O Halle-Pannenko; G Mathé; H Rappaport
Journal:  Biomedicine       Date:  1975-03

2.  An appraisal of the nitroblue tetrazolium reduction test.

Authors:  J K Lace; J S Tan; C Watanakunakorn
Journal:  Am J Med       Date:  1975-05       Impact factor: 4.965

3.  Vaginal flora in asymptomatic women.

Authors:  J H Tashjian; C B Coulam; J A Washington
Journal:  Mayo Clin Proc       Date:  1976-09       Impact factor: 7.616

Review 4.  BCG and cancer.

Authors:  R C Bast; B Zbar; T Borsos; H J Rapp
Journal:  N Engl J Med       Date:  1974-06-27       Impact factor: 91.245

Review 5.  Microflora of the vagina during pregnancy.

Authors:  R Hurley; V C Stanley; B G Leask; J De Louvois
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1974

6.  Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis.

Authors:  M G Hanna; B Zbar; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1972-05       Impact factor: 13.506

7.  Granuloma formation in lymph-nodes.

Authors:  S M Gaafar; J L Turk
Journal:  J Pathol       Date:  1970-01       Impact factor: 7.996

8.  The role of langerhans cells in contact allergy. I. An ultrastructural study in actively induced contact dermatitis in guinea pigs.

Authors:  I Silberberg; R L Baer; S A Rosenthal
Journal:  Acta Derm Venereol       Date:  1974       Impact factor: 4.437

9.  Prognostic significance of regional lymph node histology in uterine cervical cancer.

Authors:  V Tsakraklides; O T Anastassiades; J H Kersey
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

10.  Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation.

Authors:  D A Bass
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.